Drug – bio-affecting and body treating compositions – Lymphokine – Interferon
Patent
1990-11-30
1992-03-03
Rollins, John W.
Drug, bio-affecting and body treating compositions
Lymphokine
Interferon
424 855, 424 857, 514 50, A61K 3766, A61K 3170
Patent
active
050931148
ABSTRACT:
Treatment of AIDS or humans carrying or infected with the AIDS virus or having antibodies to the AIDS virus is disclosed using the compound 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof.
Also disclosed is the use of the 5'-mono-, di- and triphosphate of 3'-azido-3'-deoxythymidine or a pharmaceutically acceptable basic salt thereof for the same purpose.
REFERENCES:
patent: 3660564 (1972-05-01), Yoneda et al.
patent: 4874609 (1989-10-01), Rideout et al.
Hartshorn et al., Antimicrobial Agents and Chemotherapy, vol. 31, No. 2, Feb. 1987, Synergistic Inhibition of Human Immunodeficiency Virus In Vitro by Azidothymidine and Recombinant Alpha A Interferon, pp. 168-172.
Lane et al., The Lancet, Nov. 26, 1988, Anti-Retroviral Effects of Interferon-.alpha. In AIDS-Associated Kaposi's Sarcoma, pp. 1218-1222.
DeWit et al., The Lancet, Nov. 26, 1988, Clinical and Virological Effects of High-Dose Recombinant Interferon-.alpha. In Disseminated AIDS-Related Kaposi's Sarcoma, pp. 1214-1217.
Paper--J. Interferon Res. 7(6):774, 1987.
J. M. Yeo, Journal of Infec., 1989, 18, Supplement 1, pp. 93-96, Current and Future Trials with Zidovudine.
Ho et al., The Lancet, Mar. 16, 1985, Recombinant Human Interferon Alfa-A Suppresses HTLV-III Replication In Vitro,, pp. 602-604.
Zidovudine/Interferon Combination Therapy, Apr. 17, 1988, 17 pages.
Orholm et al., Current Science Ltd., vol. 3, No. 2, Suppression of p24 antigen in sera from HIV-infected individuals with low-dose.alpha.-interferon and zidovudine: a pilot study, pp. 97-100.
Paper--The Lancet, Jan. 21, 1989, Interferon-Alpha Plus Zidovudine in HIV Infection, p. 156.
Paper--Carron et al., No. 3633, Anti-HIV Activity of Beta-Interferon in Combinaiton with Zidovudine.
Paper--vol. 260, No. 23, Dec. 16, 1988, From the National Institutes of Health, Progress in AIDS Research, p. 3406.
Dozier et al., Drug. Intell. Clin. Pharm., 17(11), pp. 798-807, Nov. 1983, Acquired Immune Deficiency Syndrome and the Management of Associated Opportunistic Infections.
Paper--The Lancet, Jan. 30, 1988, Combination Therapy After Retroviral Inoculaiton, pp. 239-240.
Daul et al., Annals of Allergy, vol. 51, Sep. 1983, Acquired Immune Deficiency Syndrome: An Update and Interpretation, pp. 351-361.
Krieg et al., Expt Cell. Res., 116:21-29, 1978.
Hartshorn et al., Chem. Abst., 106:11320ls, 1987.
Barry David W.
Furman Phillip A.
Lehrmaan Sandra N.
Rideout Janet L.
St. Clair Martha H.
Brown Donald
Burroughs Wellcome Co.
Nielsen Lawrence A.
Rollins John W.
LandOfFree
Treatment of human viral infections does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of human viral infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of human viral infections will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-270900